CacyBP/SIP Protein Promotes Proliferation and G1/S Transition of Human Pancreatic Cancer Cells

被引:27
作者
Chen, Xiong [1 ,2 ]
Mo, Ping [1 ,2 ]
Li, Xiaohua [1 ,2 ]
Zheng, Peichan [3 ]
Zhao, Lina [1 ,2 ]
Xue, Zengfu [1 ,2 ]
Ren, Gui [1 ,2 ]
Han, Guohong [1 ,2 ]
Wang, Xin [1 ,2 ]
Fan, Daiming [1 ,2 ]
机构
[1] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China
[3] Peoples Hosp Fujian Prov, Dept Clin Lab, Fuzhou, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
CacyBP/SIP; proliferation; cell cycle; pancreatic cancer; BINDING-PROTEIN; SIGNALING PATHWAY; CALCYCLIN; EXPRESSION; PROSTATE; APOPTOSIS; RECEPTOR; DIFFERENTIATION; TARGET; GROWTH;
D O I
10.1002/mc.20737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calcyclin-binding protein or Siah-1-interacting protein (CacyBP/SIP), a component of the ubiquitin-mediated proteolysis, could participate in beta-catenin degradation, which was found to be related to the malignant phenotypes of pancreatic cancer previously. However, the role of CacyBP/SIP itself in pancreatic cancer has not been investigated. In the present study, CacyBP/SIP expression was assayed and manipulated to reveal the potential mechanism in pancreatic cancer carcinogenesis. Here, we show that CacyBP/SIP is over-expressed in pancreatic cancer cells. Down-regulation of CacyBP/SIP by small interference RNA (siRNA) severely suppresses the proliferation and tumorigenesis in pancreatic cancer. G1/S transition arrest induced by inhibition of CacyBP/SIP is at least partly mediated by down-regulation of Cyclin E and CDK2 as well as up-regulation of p27 and Rb. Collectively, CacyBP/SIP as an enhancer of pancreatic cancer malignance might develop into another possible therapeutic target. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:804 / 811
页数:8
相关论文
共 30 条
[11]   CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1 [J].
Kilanczyk, Ewa ;
Filipek, Slawomir ;
Jastrzebska, Beata ;
Filipek, Anna .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (01) :54-59
[12]   Pancreatic cancer [J].
Li, DH ;
Xie, KP ;
Wolff, R ;
Abbruzzese, JL .
LANCET, 2004, 363 (9414) :1049-1057
[13]   Mechanisms by Which the Antitumor Compound Di-n-Butyl-Di-(4-Chlorobenzohydroxamato)Tin(IV) Induces Apoptosis and the Mitochondrial-Mediated Signaling Pathway in Human Cancer SGC-7901 Cells [J].
Li, Yunlan ;
Liu, Jinjie ;
Li, Qingshan .
MOLECULAR CARCINOGENESIS, 2010, 49 (06) :566-581
[14]   Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway [J].
Matigian, N. ;
Windus, L. ;
Smith, H. ;
Filippich, C. ;
Pantelis, C. ;
McGrath, J. ;
Mowry, B. ;
Hayward, N. .
MOLECULAR PSYCHIATRY, 2007, 12 (09) :815-825
[15]   Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses [J].
Matsuzawa, S ;
Reed, JC .
MOLECULAR CELL, 2001, 7 (05) :915-926
[16]   Neurotrophin signalling pathways regulating neuronal apoptosis [J].
Miller, FD ;
Kaplan, DR .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (08) :1045-1053
[17]  
Milner AE, 1998, METH MOL B, V80, P347
[18]   Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer [J].
Ning, Xiaoxuan ;
Sun, Shiren ;
Hong, Liu ;
Liang, Jie ;
Liu, Lili ;
Han, Shuang ;
Liu, Zhiguo ;
Shi, Yongquan ;
Li, Yuan ;
Gong, Weiqin ;
Zhang, Shanhong ;
Chen, Yu ;
Guo, Xueyan ;
Cheng, Yi ;
Wu, Kaichun ;
Fan, Daiming .
MOLECULAR CANCER RESEARCH, 2007, 5 (12) :1254-1262
[19]  
Perez M, 1997, PROSTATE, V30, P274, DOI 10.1002/(SICI)1097-0045(19970301)30:4<274::AID-PROS8>3.0.CO
[20]  
2-L